TLPH Q2 2018 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena

TLPHTalphera, Inc.

$18M

Q2 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$818,000-69.2% YoY

Gross Profit

-$3M-392.3% margin

Operating Income

-$7M-874.4% margin

Net Income

-$11M-1288.6% margin

EPS (Diluted)

$-4.07

QoQ Revenue Growth

+138.5%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$7M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$65M

Total Liabilities

$114M

Stockholders' Equity

-$49M

Cash & Equivalents

$33M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$818,000	$3M	-69.2%
Gross Profit	-$3M	-$6M	+44.5%
Operating Income	-$7M	-$10M	+28.0%
Net Income	-$11M	-$13M	+19.3%